|
ZNF232 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.331900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.029980E-01 |
| Normal-vs-Stage2 |
9.867800E-02 |
| Normal-vs-Stage3 |
3.420000E-02 |
| Normal-vs-Stage4 |
6.944600E-03 |
| Stage1-vs-Stage2 |
7.188600E-01 |
| Stage1-vs-Stage3 |
5.016000E-01 |
| Stage1-vs-Stage4 |
1.388620E-01 |
| Stage2-vs-Stage3 |
9.023000E-01 |
| Stage2-vs-Stage4 |
4.946400E-01 |
| Stage3-vs-Stage4 |
4.653000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.097700E-02 |
| Normal-vs-AfricanAmerican |
1.657790E-01 |
| Normal-vs-Asian |
2.117600E-03 |
| Caucasian-vs-AfricanAmerican |
7.062800E-01 |
| Caucasian-vs-Asian |
2.888300E-02 |
| AfricanAmerican-vs-Asian |
5.896200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.160100E-02 |
| Normal-vs-Female |
4.593600E-02 |
| Male-vs-Female |
8.806200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.258210E-02 |
| Normal-vs-Age(41-60Yrs) |
9.427600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.724000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.317800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.637600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.655200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.588600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.310200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.850200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.491200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.305800E-02 |
| Classical-VS-Follicular |
1.152800E-01 |
| Classical-VS-Other |
4.645800E-01 |
| Classical-VS-Normal |
1.439390E-01 |
| Tall-VS-Follicular |
5.615800E-01 |
| Tall-VS-Other |
2.474000E-01 |
| Tall-VS-Normal |
7.475900E-03 |
| Follicular-VS-Other |
2.581400E-01 |
| Follicular-VS-Normal |
2.138100E-02 |
| Other-VS-Normal |
8.899000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.063640E-01 |
| Normal-vs-N1 |
2.946100E-02 |
| N0-vs-N1 |
3.095400E-01 |
|
|
